Long Crendon, Buckinghamshire, UK, 18 December 2017 – Softbox Systems, a leading global innovator and provider of temperature control packaging for the pharmaceutical industry, today announces the appointment of Clive Bryant as Global Senior Business Development Director, a new global innovation leadership role within Softbox Systems. Clive will report to the Softbox Systems President, Wayne Langlois.
In this new global leadership role, Clive will be responsible for the strategic management of Softbox Systems’ new products and services that will be launched over the next few years. He will work with the Softbox Systems innovation design team, regional leaders, marketing and sales teams, and key global customers, to ensure all new innovations meet emerging customer needs. Clive brings over 30 years’ leadership experience in cold chain for pharma and pharma logistics industries.
With Clive assuming his new role, Softbox Systems announces the appointment of Alex Keeling as new European Sales Manager. Alex has worked in leadership roles for a number of global Blue Chip and Logistics companies, with significant exposure to the Pharma and Healthcare sectors. He also brings over 30 years’ experience in business development strategy and execution.
Alex will be responsible for the strategic leadership of the European sales team and will contribute to the overall global growth strategy for Softbox Systems while leading the business to achieve further success in Europe.
Wayne Langlois, President at Softbox Systems, commented: “With Softbox Systems growing very quickly and innovating very rapidly, I am committed to deepening our leadership team in bringing new products and services to market, with high quality in both strategy and execution, to satisfy our global client expectations.”
About Softbox Systems
Softbox Systems is an award winning temperature control packaging innovator that has been designing and producing high performance passive temperature control packaging solutions for over 20 years. We offer consistent quality to our clients from our strategically located global manufacturing sites throughout Europe, North America, Latin America and Asia Pacific.
We have formed long standing partnerships with the world’s leading pharmaceutical, clinical research, biotech and logistics companies, and apply innovative thinking to overcome the challenges that our clients face in managing the Cold Chain when shipping temperature sensitive clinical trial and commercialised products.
In 2014, Great Point Partners, a leading health care investment firm, recapitalised Softbox Systems to provide growth financing for the Company to continue to execute on its expansion, innovation and global investment strategy to support its clients around the globe.
Softbox Systems – Enabling Cold Chain Excellence